...whole-body LLL exposure in larger animal models of thrombocytopenia. TARGET/MARKER/PATHWAY: Integrin α2b ( GPIIb ; CD41...

...information; the company did not respond to inquiries. The non-peptide integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...

...treat patients undergoing percutaneous coronary intervention (PCI) with use of integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...

...treat patients undergoing percutaneous coronary intervention (PCI) with use of integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/...

...sales of the other company’s product. Aggrastat is a non-peptide integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...

...exclusive rights to commercialize Aggrastat tirofiban in China. The non-peptide integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...

...company expects a PDUFA date in July 2016. The non-peptide integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...

...also seeks to include a high-dose bolus administration of Aggrastat. The non-peptide Integrin alpha(2b)beta(3) (GPIIb/IIIa) (CD41/CD61...

...treat patients undergoing percutaneous coronary intervention (PCI) with use of integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...

...a P2Y12 platelet inhibitor and are not being given an integrin alpha(2b)beta(3) ( GPIIb/IIIa ; CD41/CD61...